Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Takeda Pharmaceutical Co Ltd ADR stock

Learn how to easily invest in Takeda Pharmaceutical Co Ltd ADR stock.

Takeda Pharmaceutical Co Ltd ADR is a drug manufacturers-specialty & generic business based in the US. Takeda Pharmaceutical Co Ltd ADR shares (TAK) are listed on the NYSE and all prices are listed in US Dollars. Takeda Pharmaceutical Co Ltd ADR employs 47,347 staff and has a trailing 12-month revenue of around $3.7 trillion.

How to buy Takeda Pharmaceutical Co Ltd ADR stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – TAK. It's that simple.

Best for low fees

Finder Award

SoFi Invest


  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Best for beginners

Finder Award

eToro


  • Trade stocks and ETFs for $0 and no annual fee
  • Minimum deposit of $10 required
  • FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100

Promoted for easy user experience

Robinhood


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Takeda Pharmaceutical Co Ltd ADR stock price (NYSE: TAK)

Use our graph to track the performance of TAK stocks over time.

Takeda Pharmaceutical Co Ltd ADR shares at a glance

Information last updated 2023-02-01.
Latest market close$15.74
52-week range$12.28 - $16.30
50-day moving average $15.25
200-day moving average $14.19
Wall St. target price$18.05
PE ratio 30.3846
Dividend yield $180 (4.15%)
Earnings per share (TTM) $0.52

Buy Takeda Pharmaceutical Co Ltd ADR stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
eToro
Stocks, Options, ETFs, Cryptocurrency
$0
$10
FINDER EXCLUSIVE: Get $15
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Public.com
Stocks, ETFs, Cryptocurrency, Alternatives
$0
$0
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
$0
$0
N/A
Winner of Finder’s Best Overall Stock Broker award.
loading

Compare up to 4 providers

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Takeda Pharmaceutical Co Ltd ADR stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Takeda Pharmaceutical Co Ltd ADR price performance over time

Historical closes compared with the close of $15.74 from 2023-02-02

1 week (2023-01-27) -1.81%
1 month (2023-01-03) -0.13%
3 months (2022-11-03) 20.06%
6 months (2022-08-03) 13.32%
1 year (2022-02-03) 9.00%
2 years (2021-02-03) -9.70%
3 years (2020-02-03) 19.36
5 years (2018-02-02) 29.515

Is Takeda Pharmaceutical Co Ltd ADR stock undervalued or overvalued?

Valuing Takeda Pharmaceutical Co Ltd ADR stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Takeda Pharmaceutical Co Ltd ADR's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Takeda Pharmaceutical Co Ltd ADR's P/E ratio

Takeda Pharmaceutical Co Ltd ADR's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 30x. In other words, Takeda Pharmaceutical Co Ltd ADR shares trade at around 30x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Takeda Pharmaceutical Co Ltd ADR's PEG ratio

Takeda Pharmaceutical Co Ltd ADR's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.5932. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Takeda Pharmaceutical Co Ltd ADR's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Takeda Pharmaceutical Co Ltd ADR's EBITDA

Takeda Pharmaceutical Co Ltd ADR's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1,048.8 billion.

The EBITDA is a measure of a Takeda Pharmaceutical Co Ltd ADR's overall financial performance and is widely used to measure a its profitability.

Takeda Pharmaceutical Co Ltd ADR financials

Revenue TTM $3,749.4 billion
Operating margin TTM 13.16%
Gross profit TTM $2,441.7 billion
Return on assets TTM 2.27%
Return on equity TTM 3.54%
Profit margin 5.69%
Book value $2,159.04
Market capitalisation $49.2 billion

TTM: trailing 12 months

Takeda Pharmaceutical Co Ltd ADR share dividends

2%

Dividend payout ratio: 1.75% of net profits

Recently Takeda Pharmaceutical Co Ltd ADR has paid out, on average, around 1.75% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 4.15% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Takeda Pharmaceutical Co Ltd ADR shareholders could enjoy a 4.15% return on their shares, in the form of dividend payments. In Takeda Pharmaceutical Co Ltd ADR's case, that would currently equate to about $180 per share.

While Takeda Pharmaceutical Co Ltd ADR's payout ratio might seem low, this can signify that Takeda Pharmaceutical Co Ltd ADR is investing more in its future growth.

Takeda Pharmaceutical Co Ltd ADR's most recent dividend payout was on 14 December 2009. The latest dividend was paid out to all shareholders who bought their shares by 28 September 2022 (the "ex-dividend date").

Takeda Pharmaceutical Co Ltd ADR share price volatility

Over the last 12 months, Takeda Pharmaceutical Co Ltd ADR's shares have ranged in value from as little as $12.28 up to $16.3. A popular way to gauge a stock's volatility is its "beta".

TAK.US volatility(beta: 0.73)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Takeda Pharmaceutical Co Ltd ADR's is 0.7271. This would suggest that Takeda Pharmaceutical Co Ltd ADR's shares are less volatile than average (for this exchange).

Takeda Pharmaceutical Co Ltd ADR overview

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab, Alofisel, Dexilant, Natpara, Adynovate/Adynovi, Takhzyro, Livtencity, Elaprase, Replagal, Advate, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, Velcade, Leuplin/Enantone, Adcetris, Vyvansese, Trintellix, and Alunbrig brands. Takeda Pharmaceutical Company Limited has out-licensing agreement with Neurocrine Biosciences, Inc. ; collaborations and in-licensing agreements with the University of Texas MD Anderson Cancer Center, Arrowhead Pharmaceuticals Inc. , and Ovid Therapeutics Inc. ; and collaboration with Evox Therapeutics Ltd.

Frequently asked questions

What percentage of Takeda Pharmaceutical Co Ltd ADR is owned by institutions?
Currently 2.135% of Takeda Pharmaceutical Co Ltd ADR shares are held by institutions.
How many people work for Takeda Pharmaceutical Co Ltd ADR?
Latest data suggests 47,347 work at Takeda Pharmaceutical Co Ltd ADR.
When does the fiscal year end for Takeda Pharmaceutical Co Ltd ADR?
Takeda Pharmaceutical Co Ltd ADR's fiscal year ends in March.
Where is Takeda Pharmaceutical Co Ltd ADR based?
Takeda Pharmaceutical Co Ltd ADR's address is: 1-1, Nihonbashi-Honcho 2-chome, Tokyo, Japan, 103-8668
What is Takeda Pharmaceutical Co Ltd ADR's ISIN number?
Takeda Pharmaceutical Co Ltd ADR's international securities identification number is: US8740602052
What is Takeda Pharmaceutical Co Ltd ADR's CUSIP number?
Takeda Pharmaceutical Co Ltd ADR's Committee on Uniform Securities Identification Procedures number is: 874060106

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site